Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Travel Med Infect Dis ; 42: 102064, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33878449

RESUMEN

BACKGROUND: The first case of the novel coronavirus disease 2019 (COVID-19) in Libya was diagnosed in March 2020. We aimed to determine the epidemiological, clinical, and laboratory characteristics of COVID-19 in Libya. METHOD: In this retrospective descriptive study, we analyzed the demographics, initial clinical presentation, history, comorbidities, laboratory findings, complications, and outcomes of hospitalized patients with COVID-19 at several centers in the Western part of Libya between March 24, 2020, and December 3, 2020. RESULTS: The study included 811 (67.2%) men and 396 (32.8%) women. The median (interquartile range [IQR]) age was 56 (40-64). A total of 173 (14.3%) patients developed respiratory distress syndrome, while 70 (5.8%) developed circulatory shock and hypotension; 190 (15.7%) were admitted to the intensive care unit. Acute cardiac injury occurred in 27 (2.2%) patients, and 45 (3.7%) developed arrhythmia. Acute kidney injury occurred in 44 (3.6%) patients. Of the patients admitted during the study period, 149 (12.3%) died. The predominant comorbidities ordered in a descending manner were as follows; diabetes mellitus, presented 490 (40.6%), hypertension in 414 (34.3%), chronic kidney disease in 114 (9.4%), and lung diseases in 103 (8.5%). The total white blood cell, neutrophil; monocyte; D-dimer; creatinine kinase; creatine kinase-MB; creatinine; total bilirubin; alanine and aspartate aminotransferase; and hypersensitive troponin were increased among non-survivors, whereas lymphocyte and platelet counts were decreased among non-survivors. CONCLUSION: This is the first report of the clinical presentations and laboratory findings in patients hospitalized with COVID-19 in Libya. Libyan authorities must implement several restrictions to control the pandemic. However, incoming international travelers pose a challenge to the local authorities, especially with the recent discovery of new variants.


Asunto(s)
COVID-19/diagnóstico , COVID-19/epidemiología , Hospitalización/estadística & datos numéricos , Adulto , COVID-19/virología , Femenino , Humanos , Libia/epidemiología , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , SARS-CoV-2
2.
Andrologia ; 53(4): e13997, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-33559168

RESUMEN

This study aimed to assess the effectiveness of low-intensity extracorporeal shockwave therapy (Li-ESWT) in the management of erectile dysfunction in diabetic patients with mixed vasculogenic and neurogenic causes as confirmed by nerve conduction and Doppler studies. This randomised controlled trial included 42 patients 41-55 years of age with a confirmed diagnosis of erectile dysfunction and diabetic polyneuropathy. They were randomly allocated to one of two groups: shock wave group (n = 21) treated with Li-ESWT plus pelvic floor muscle training and control Group (n = 21) treated with pelvic floor muscle exercise and sham therapy by a shock wave. The erectile function was scored according to the five-item version of the International Index of Erectile Function (IIEF-5). Colour-coded duplex sonography was used for the evaluation of penile perfusion of the two cavernous arteries. The assessment was done before and three months after treatment. IIEF-EF increased significantly in the study group (p < .001), but not in the control group (p = .194). Peak systolic velocity increased significantly in the two groups; however, the post-treatment peak systolic velocity was significantly higher in the study group compared to the control group (p < .001, for both arteries).


Asunto(s)
Diabetes Mellitus , Disfunción Eréctil , Tratamiento con Ondas de Choque Extracorpóreas , Disfunción Eréctil/etiología , Disfunción Eréctil/terapia , Humanos , Masculino , Erección Peniana , Pene/diagnóstico por imagen
3.
Br Poult Sci ; 58(3): 319-328, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28097888

RESUMEN

1. The main aim of this work is to develop a robust method to generate a microbial mixture which can successfully degrade poultry feathers to overcome environmental problems. 2. Four different alkaliphilic microbes were isolated and shown to degrade poultry feathers. 3. Two of the isolates were phylogenetically identified as Lysinibacillus and the others were identified as Nocardiopsis and Micrococcus. 4. The best microbial co-culture for white and black feather degradation was optimised for pH, temperature and relative population of the isolates to achieve almost 96% of degradation compared with a maximum of 31% when applying each isolate individually. 5. The maximum activity of keratinase was estimated to be 1.5 U/ml after 3 d for white feathers and 0.6 U/ml after 4 d for black feathers in a basal medium containing feather as the main carbon source. Additionally, non-denaturing polyacrylamide gel electrophoresis showed 4 and 3 protease activity bands for white and black feather, respectively. 6. This study provides a robust method to develop potential new mixtures of microorganisms that are able to degrade both white and black feathers by applying a Central Composite Design.


Asunto(s)
Crianza de Animales Domésticos/métodos , Proteínas Bacterianas/metabolismo , Pollos , Plumas , Bacterias Grampositivas/metabolismo , Péptido Hidrolasas/metabolismo , Actinobacteria/clasificación , Actinobacteria/genética , Actinobacteria/metabolismo , Animales , Bacillaceae/clasificación , Bacillaceae/genética , Bacillaceae/metabolismo , Biodegradación Ambiental , Plumas/química , Bacterias Grampositivas/clasificación , Bacterias Grampositivas/genética , Residuos Industriales , Micrococcus/clasificación , Micrococcus/genética , Micrococcus/metabolismo , Filogenia , Pigmentación , ARN Bacteriano/análisis , ARN Ribosómico 16S/análisis , Análisis de Secuencia de ADN/veterinaria
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA